Kazia Therapeutics | F-1: Registration statement for securities of certain foreign private issuers
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Kazia Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Kazia Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals
Kazia Therapeutics | EFFECT: Others
Kazia Therapeutics | 424B3: Prospectus
Kazia Therapeutics | CORRESP: CORRESP
Kazia Therapeutics | UPLOAD: Others
No Data